1 - 6 of 6 articles
The association between the immune system and malignancy is at the forefront of research aimed at identifying and developing effective immunotherapies to treat and suppress cancer. Understanding the mechanisms underlying the biology, differentiation and effector functions of key immune cells in...
Effective antitumor responses require communication between antigen‐presenting cells, T‐cell subsets, B cells and natural killer cells. However, tumors have developed a number of mechanisms to avoid detection and elimination by the immune system. This results in a microenvironment that can...
There has been much recent attention on immunotherapy for cancer due to the promising results of several randomized phase‐III trials. The management of metastatic melanoma in particular is a significant clinical challenge, and it has long been a desired target of immunotherapies due to evidence...
The use of monoclonal antibodies for the treatment of cancer has generated increasing interest in recent years as more antibodies become available and demonstrate clinical utility. This article reviews the available evidence for the use of three monoclonal antibodies: one – ipilimumab – pending...
Read and print from thousands of top scholarly journals.
Continue with Facebook
Log in with Microsoft
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Sign Up Log In
To subscribe to email alerts, please log in first, or sign up for a DeepDyve account if you don’t already have one.
To get new article updates from a journal on your personalized homepage, please log in first, or sign up for a DeepDyve account if you don’t already have one.